https://dovitinibinhibitor.com..../your-mind-wellness-
MIBG). The novel PET-radiotracer F-18-flubrobenguane could change the diagnostic paradigm in suspected pheochromocytomas and paragangliomas due to its homology to MIBG while the general advantages of PET-imaging. Goal of this retrospective evaluation would be to evaluate F-18-flubrobenguane in pheochromocytomas and paragangliomas and also to explore the biodistribution in patients. Methods 24 clients with suspected pheochromocytoma and paraganglioma underwent PET/CT or PET/MRI at 63±24 min p.i. after shot of 256±
Me gusta
Comentario
Compartir
